We performed a comparative evaluation of clinical characteristics of metabolism subtypes as observed in the TCGA-GBM dataset, and no significant differences between metabolism subtypes in terms of age, sex, 1p/19q codeletion, or O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation were observed (Figure. This evidence concerns the gene MGMT and glioblastoma.